Table 2 Univariate Cox proportional hazards analyses of LINC00662 expression and overall survival for patients with colon cancer
| Â | HR (95% CI) | P-value |
|---|---|---|
LINC00662 | ||
 low vs high | 0.35 (0.133–0.919) | 0.033* |
Age | ||
  < 60 vs > =60 | 0.988 (0.55–1.775) | 0.968 |
Gender | ||
 male vs female | 1.019 (0.577–1.798) | 0.95 |
Location | ||
 Left vs right | 0.586 (0.322–1.065) | 0.08 |
Histology | ||
 Adenocarcinoma vs Mucinous adenocarcinoma | 0.952 (0.539–1.681) | 0.865 |
Stage | ||
 I + II vs III + IV | 1.825 (0.834–3.994) | 0.132 |
T stage | ||
 Tis vs T1-T3 | 1.734 (0.947–3.173) | 0.074 |
N stage | ||
 N0 vs N1 + N2 | 0.803 (0.44–1.464) | 0.473 |
M stage | ||
 M0 vs M1 | 1.011 (0.496–2.062) | 0.975 |